Johnson & Johnson Proposes $5.5 Billion Settlement for Talc Lawsuits

Pharmaceutical giant Johnson & Johnson has agreed to a $5.5 billion settlement to resolve approximately 69,000 lawsuits in the U.S. alleging its talc-based baby powder caused ovarian cancer.

The proposed settlement, which covers 99.75 percent of outstanding U.S. talc cases, requires acceptance by 95 percent of claimants to become final and legally binding for the company.

This agreement excludes ongoing litigation in the United Kingdom, where a separate case filed in October 2025 involves more than 7,000 potential claimants currently before the UK High Court.